Rapid emergence of third-generation cephalosporin resistance in Shigella Sp. isolated in andaman and Nicobar Islands, India

Microbial Drug Resistance

Volumn 17, Issue 2, 2011, Pages 329-332

  Bhattacharya, Debdutta ^a   Purushottaman, Sugunan Attayur ^a   Bhattacharjee, Haimanti ^a   Thamizhmani, Ramanathan ^a   Sudharama, Sayi Devarajan ^a   Manimunda, Sathya Prakash ^a   Bharadwaj, Ageshwar Prasad ^b   Singhania, Munni ^c   Roy, Subarna ^a  

^a INDIAN COUNCIL OF MEDICAL RESEARCH   (India)

^b Chirayu Child Care Centre   (India)

^c G B PANT HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZITHROMYCIN; CARBENICILLIN; CEFALOTIN; CEFIXIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; GATIFLOXACIN; GENTAMICIN; IMIPENEM; NALIDIXIC ACID; NITROFURANTOIN; NORFLOXACIN; OFLOXACIN; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CHILD; CONTROLLED STUDY; DEVELOPING COUNTRY; FECES ANALYSIS; FEMALE; HUMAN; INDIA; INFANT; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; NUCLEOTIDE SEQUENCE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SHIGELLA; SHIGELLA DYSENTERIAE; SHIGELLA FLEXNERI; SHIGELLOSIS; SPECIES DISTRIBUTION;

ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; BETA-LACTAMASES; CEPHALOSPORIN RESISTANCE; CEPHALOSPORINS; CHILD; CHILD, PRESCHOOL; DEVELOPING COUNTRIES; DIARRHEA; DISK DIFFUSION ANTIMICROBIAL TESTS; DYSENTERY, BACILLARY; FECES; FEMALE; GEOGRAPHY; HUMANS; INDIA; INFANT; MALE; MICROBIAL SENSITIVITY TESTS; MULTILOCUS SEQUENCE TYPING; SHIGELLA DYSENTERIAE; SHIGELLA FLEXNERI;

SHIGELLA; SHIGELLA DYSENTERIAE; SHIGELLA FLEXNERI; SHIGELLA SP.;

EID: 79957636717     PISSN: 10766294     EISSN: 19318448     Source Type: Journal    
DOI: 10.1089/mdr.2010.0084     Document Type: Article

References (17)

1. Ashkenazi, S., I. Levy, V. Kazaronovski, and Z. Samra. Growing antimicrobial resistance of Shigella isolates. J. Antimicrob. Chemother. 51:819-823.
2. Bennish, M.L., J.R. Harris, B.J. Wojtyniak, and M. Struelens. Death in shigellosis: incidence and risk factors in hospitalized patients. J. Infect. Dis. 160:500-506.
3. [CLSI] Clinical and Laboratory Standards Institute. 2007. Performance Standards for Antimicrobial Disk Susceptibility Tests. Approved Standard M2-A10. CLSI, Wayne, PA.
4. Fortineau, N., T. Naas, O. Gaillot, and P. Nordmann. 2001. SHV-type extended-spectrum b-lactamase in a Shigella flexneri clinical isolate. J. Antimicrob. Chemother. 47:685-688. (Pubitemid 32447661)
5. Ghosh, A.R., and S.C. Sehgal. 1996. Existing status of shigellosis in Andaman & Nicobar Islands. Indian J. Med. Res. 103:134-137.
6. Ghosh, A.R., and S.C. Sehgal. 1998. Shigella infections among children in Andaman-an archipelago of tropical islands in Bay of Bengal. Epidemiol. Infect. 121:43-48. (Pubitemid 28423328)
7. Jesudason, M.V., M.K. Lalitha, and G. Koshi. 1985. Changes in incidence of shigella subgroups and their antibiotic susceptibility pattern in Vellore, South India. J. Trop. Med. Hyg. 88:355-358. (Pubitemid 16071057)
8. Kim, S., J. Kim, Y. Kang, Y. Park, and B. Lee. 2004. Occurrence of extended-spectrum b-lactamases in members of the genus Shigella in the Republic of Korea. J. Clin. Microbiol. 42:5264-5269. (Pubitemid 39506239)
9. Kotloff, K.L., J.P. Winickoff, B. Ivanoff, J.D. Clemens, D.L. Swerdlow, P.J. Samsonetti, G.K. Adak, and M.M. Levine. Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. Bull. World Health Organ. 77:651-666.
10. Lefort, A., G. Arlet, O.F. Join-Lambert, M. Lecuit, and O. Lortholary. 2007. Novel extended-spectrum b-lactamase in Shigella sonnei. Emerg. Infect. Dis. 13:653-654. (Pubitemid 46525126)
11. Mandal, J., N. Mondal, S. Mahadevan, and S.C. Parija. Emergence of resistance to third-generation cephalosporin in Shigella-a case report. J. Trop. Pediatr. 56: 278-279.
12. Maynard, C., J.M. Fairbrother, S. Bekal, F. Sanschagrin, R.C. Levesque, R. Brousseau, L. Masson, S. Lariviere, and J. Harel. 2003. Antimicrobial resistance genes in enterotoxigenic Escherichia coli O149:K91 isolates obtained over a 23-year period from pigs. Antimicrob. Agents. Chemother. 47:3214-3221. (Pubitemid 37229581)
13. Rademaker, J.L.W., and F.J. DeBruijn. 1997. Characterization and classification of microbes by REP-PCR genomic fingerprinting and computer assisted pattern analysis. In G. Caetano-Anolles and P.M. Gresshoff (eds.), DNA Markers-Protocols, Applications, and Overviews, 1st edition. Wiley-VCH, New York, pp. 51-171.
14. Rahman, M., S. Shoma, H. Rashid, A.K. Siddique, G.B. Nair, and D.A. Sack. 2004. Extended spectrum b-lactamasemediated third generation cephalosporin resistance in Shigella isolates in Bangladesh. J. Antimicrob. Chemother. 54:846-847. (Pubitemid 39386746)
15. Roy, S., K. Thanasekaran, A.R. DuttaRoy, and S.C. Sehgal. Distribution of Shigella enterotoxin genes and secreted autotransporter toxin gene among diverse species and serotypes of Shigella isolated from Andaman Islands, India. Trop. Med. Int. Health 11:1694-1698.
16. Sen, D., A.K. Sinha, P.G. Sengupta, S.C. Pal, S.K. Bhattacharya, and R. Lall. 1986. Epidemic shiga bacillus dysentery in Port Blair, Andaman & Nicobar Islands, India. J. Diarrhoeal Dis. Res. 4:161-162.
17. [WHO] World Health Organization. Guidelines for the Control of Shigellosis, Including Epidemics Due to Shigella dysenteriae Type 1. Available at http://whqlibdoc.who.int/publications/2005/9241592330.pdf. Geneva: WHO, 2005. 7th May, 2010 (Online.)